B型肝炎ウイルス(HBV)世界市場の発展状況と動向 2024-2030
英文タイトル: Global Hepatitis B Virus (HBV) Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書はB型肝炎ウイルス(HBV)市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはB型肝炎ウイルス(HBV)の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界のB型肝炎ウイルス(HBV)市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはB型肝炎ウイルス(HBV)のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にB型肝炎ウイルス(HBV)市場を分類しています。本研究に含まれる主な企業は:Merck、Gilead Sciences、Novartis、GlaxoSmithKline、Hoffmann、La Roche、Bristol-Myers Squibb
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Therapeutics
Vaccine
用途別の市場セグメント:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
本レポートの詳細内容
世界のB型肝炎ウイルス(HBV)市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、B型肝炎ウイルス(HBV)タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のB型肝炎ウイルス(HBV)収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のB型肝炎ウイルス(HBV)市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、B型肝炎ウイルス(HBV)市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
B型肝炎ウイルス(HBV)のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:B型肝炎ウイルス(HBV)のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:B型肝炎ウイルス(HBV)の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章B型肝炎ウイルス(HBV)企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:B型肝炎ウイルス(HBV)の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:B型肝炎ウイルス(HBV)の主要企業の概要を提供し、製品の説明と仕様、B型肝炎ウイルス(HBV)の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle. Market Analysis and Insights: Global Hepatitis B Virus (HBV) Market The global Hepatitis B Virus (HBV) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group. Report Covers: This report presents an overview of global market for Hepatitis B Virus (HBV) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Hepatitis B Virus (HBV), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hepatitis B Virus (HBV), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Hepatitis B Virus (HBV) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hepatitis B Virus (HBV) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hepatitis B Virus (HBV) revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Merck, Gilead Sciences, Novartis, GlaxoSmithKline, Hoffmann, La Roche and Bristol-Myers Squibb, etc. Market Segmentation By Company Merck Gilead Sciences Novartis GlaxoSmithKline Hoffmann La Roche Bristol-Myers Squibb Segment by Type Therapeutics Vaccine Segment by Application Hospitals Ambulatory Surgical Centers Diagnostic Centers By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Hepatitis B Virus (HBV) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Hepatitis B Virus (HBV) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis B Virus (HBV) revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B Virus (HBV) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Therapeutics
1.2.3 Vaccine
1.3 Market by Application
1.3.1 Global Hepatitis B Virus (HBV) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B Virus (HBV) Market Perspective (2019-2030)
2.2 Global Hepatitis B Virus (HBV) Growth Trends by Region
2.2.1 Hepatitis B Virus (HBV) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hepatitis B Virus (HBV) Historic Market Size by Region (2019-2024)
2.2.3 Hepatitis B Virus (HBV) Forecasted Market Size by Region (2025-2030)
2.3 Hepatitis B Virus (HBV) Market Dynamics
2.3.1 Hepatitis B Virus (HBV) Industry Trends
2.3.2 Hepatitis B Virus (HBV) Market Drivers
2.3.3 Hepatitis B Virus (HBV) Market Challenges
2.3.4 Hepatitis B Virus (HBV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hepatitis B Virus (HBV) by Players
3.1.1 Global Hepatitis B Virus (HBV) Revenue by Players (2019-2024)
3.1.2 Global Hepatitis B Virus (HBV) Revenue Market Share by Players (2019-2024)
3.2 Global Hepatitis B Virus (HBV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hepatitis B Virus (HBV), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Hepatitis B Virus (HBV) Market Concentration Ratio
3.4.1 Global Hepatitis B Virus (HBV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Virus (HBV) Revenue in 2023
3.5 Global Key Players of Hepatitis B Virus (HBV) Head office and Area Served
3.6 Global Key Players of Hepatitis B Virus (HBV), Product and Application
3.7 Global Key Players of Hepatitis B Virus (HBV), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis B Virus (HBV) Breakdown Data by Type
4.1 Global Hepatitis B Virus (HBV) Historic Market Size by Type (2019-2024)
4.2 Global Hepatitis B Virus (HBV) Forecasted Market Size by Type (2025-2030)
5 Hepatitis B Virus (HBV) Breakdown Data by Application
5.1 Global Hepatitis B Virus (HBV) Historic Market Size by Application (2019-2024)
5.2 Global Hepatitis B Virus (HBV) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hepatitis B Virus (HBV) Market Size (2019-2030)
6.2 North America Hepatitis B Virus (HBV) Market Size by Type
6.2.1 North America Hepatitis B Virus (HBV) Market Size by Type (2019-2024)
6.2.2 North America Hepatitis B Virus (HBV) Market Size by Type (2025-2030)
6.2.3 North America Hepatitis B Virus (HBV) Market Share by Type (2019-2030)
6.3 North America Hepatitis B Virus (HBV) Market Size by Application
6.3.1 North America Hepatitis B Virus (HBV) Market Size by Application (2019-2024)
6.3.2 North America Hepatitis B Virus (HBV) Market Size by Application (2025-2030)
6.3.3 North America Hepatitis B Virus (HBV) Market Share by Application (2019-2030)
6.4 North America Hepatitis B Virus (HBV) Market Size by Country
6.4.1 North America Hepatitis B Virus (HBV) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hepatitis B Virus (HBV) Market Size by Country (2019-2024)
6.4.3 North America Hepatitis B Virus (HBV) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hepatitis B Virus (HBV) Market Size (2019-2030)
7.2 Europe Hepatitis B Virus (HBV) Market Size by Type
7.2.1 Europe Hepatitis B Virus (HBV) Market Size by Type (2019-2024)
7.2.2 Europe Hepatitis B Virus (HBV) Market Size by Type (2025-2030)
7.2.3 Europe Hepatitis B Virus (HBV) Market Share by Type (2019-2030)
7.3 Europe Hepatitis B Virus (HBV) Market Size by Application
7.3.1 Europe Hepatitis B Virus (HBV) Market Size by Application (2019-2024)
7.3.2 Europe Hepatitis B Virus (HBV) Market Size by Application (2025-2030)
7.3.3 Europe Hepatitis B Virus (HBV) Market Share by Application (2019-2030)
7.4 Europe Hepatitis B Virus (HBV) Market Size by Country
7.4.1 Europe Hepatitis B Virus (HBV) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hepatitis B Virus (HBV) Market Size by Country (2019-2024)
7.4.3 Europe Hepatitis B Virus (HBV) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hepatitis B Virus (HBV) Market Size (2019-2030)
8.2 China Hepatitis B Virus (HBV) Market Size by Type
8.2.1 China Hepatitis B Virus (HBV) Market Size by Type (2019-2024)
8.2.2 China Hepatitis B Virus (HBV) Market Size by Type (2025-2030)
8.2.3 China Hepatitis B Virus (HBV) Market Share by Type (2019-2030)
8.3 China Hepatitis B Virus (HBV) Market Size by Application
8.3.1 China Hepatitis B Virus (HBV) Market Size by Application (2019-2024)
8.3.2 China Hepatitis B Virus (HBV) Market Size by Application (2025-2030)
8.3.3 China Hepatitis B Virus (HBV) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Hepatitis B Virus (HBV) Market Size (2019-2030)
9.2 Asia Hepatitis B Virus (HBV) Market Size by Type
9.2.1 Asia Hepatitis B Virus (HBV) Market Size by Type (2019-2024)
9.2.2 Asia Hepatitis B Virus (HBV) Market Size by Type (2025-2030)
9.2.3 Asia Hepatitis B Virus (HBV) Market Share by Type (2019-2030)
9.3 Asia Hepatitis B Virus (HBV) Market Size by Application
9.3.1 Asia Hepatitis B Virus (HBV) Market Size by Application (2019-2024)
9.3.2 Asia Hepatitis B Virus (HBV) Market Size by Application (2025-2030)
9.3.3 Asia Hepatitis B Virus (HBV) Market Share by Application (2019-2030)
9.4 Asia Hepatitis B Virus (HBV) Market Size by Region
9.4.1 Asia Hepatitis B Virus (HBV) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Hepatitis B Virus (HBV) Market Size by Region (2019-2024)
9.4.3 Asia Hepatitis B Virus (HBV) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Hepatitis B Virus (HBV) Introduction
11.1.4 Merck Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.1.5 Merck Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Hepatitis B Virus (HBV) Introduction
11.2.4 Gilead Sciences Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Hepatitis B Virus (HBV) Introduction
11.3.4 Novartis Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Hepatitis B Virus (HBV) Introduction
11.4.4 GlaxoSmithKline Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Hoffmann
11.5.1 Hoffmann Company Details
11.5.2 Hoffmann Business Overview
11.5.3 Hoffmann Hepatitis B Virus (HBV) Introduction
11.5.4 Hoffmann Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.5.5 Hoffmann Recent Developments
11.6 La Roche
11.6.1 La Roche Company Details
11.6.2 La Roche Business Overview
11.6.3 La Roche Hepatitis B Virus (HBV) Introduction
11.6.4 La Roche Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.6.5 La Roche Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Hepatitis B Virus (HBV) Introduction
11.7.4 Bristol-Myers Squibb Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Hepatitis B Virus (HBV) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Therapeutics Table 3. Key Players of Vaccine Table 4. Global Hepatitis B Virus (HBV) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Hepatitis B Virus (HBV) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Hepatitis B Virus (HBV) Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Hepatitis B Virus (HBV) Market Share by Region (2019-2024) Table 8. Global Hepatitis B Virus (HBV) Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Hepatitis B Virus (HBV) Market Share by Region (2025-2030) Table 10. Hepatitis B Virus (HBV) Market Trends Table 11. Hepatitis B Virus (HBV) Market Drivers Table 12. Hepatitis B Virus (HBV) Market Challenges Table 13. Hepatitis B Virus (HBV) Market Restraints Table 14. Global Hepatitis B Virus (HBV) Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Hepatitis B Virus (HBV) Revenue Share by Players (2019-2024) Table 16. Global Top Hepatitis B Virus (HBV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Virus (HBV) as of 2023) Table 17. Global Hepatitis B Virus (HBV) Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Hepatitis B Virus (HBV) Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Hepatitis B Virus (HBV), Headquarters and Area Served Table 20. Global Key Players of Hepatitis B Virus (HBV), Product and Application Table 21. Global Key Players of Hepatitis B Virus (HBV), Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hepatitis B Virus (HBV) Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Hepatitis B Virus (HBV) Revenue Market Share by Type (2019-2024) Table 25. Global Hepatitis B Virus (HBV) Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Hepatitis B Virus (HBV) Revenue Market Share by Type (2025-2030) Table 27. Global Hepatitis B Virus (HBV) Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Hepatitis B Virus (HBV) Revenue Share by Application (2019-2024) Table 29. Global Hepatitis B Virus (HBV) Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Hepatitis B Virus (HBV) Revenue Share by Application (2025-2030) Table 31. North America Hepatitis B Virus (HBV) Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Hepatitis B Virus (HBV) Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Hepatitis B Virus (HBV) Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Hepatitis B Virus (HBV) Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Hepatitis B Virus (HBV) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Hepatitis B Virus (HBV) Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Hepatitis B Virus (HBV) Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Hepatitis B Virus (HBV) Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Hepatitis B Virus (HBV) Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Hepatitis B Virus (HBV) Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Hepatitis B Virus (HBV) Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Hepatitis B Virus (HBV) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Hepatitis B Virus (HBV) Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Hepatitis B Virus (HBV) Market Size by Country (2025-2030) & (US$ Million) Table 45. China Hepatitis B Virus (HBV) Market Size by Type (2019-2024) & (US$ Million) Table 46. China Hepatitis B Virus (HBV) Market Size by Type (2025-2030) & (US$ Million) Table 47. China Hepatitis B Virus (HBV) Market Size by Application (2019-2024) & (US$ Million) Table 48. China Hepatitis B Virus (HBV) Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Hepatitis B Virus (HBV) Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Hepatitis B Virus (HBV) Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Hepatitis B Virus (HBV) Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Hepatitis B Virus (HBV) Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Hepatitis B Virus (HBV) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Hepatitis B Virus (HBV) Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Hepatitis B Virus (HBV) Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size by Country (2025-2030) & (US$ Million) Table 63. Merck Company Details Table 64. Merck Business Overview Table 65. Merck Hepatitis B Virus (HBV) Product Table 66. Merck Revenue in Hepatitis B Virus (HBV) Business (2019-2024) & (US$ Million) Table 67. Merck Recent Developments Table 68. Gilead Sciences Company Details Table 69. Gilead Sciences Business Overview Table 70. Gilead Sciences Hepatitis B Virus (HBV) Product Table 71. Gilead Sciences Revenue in Hepatitis B Virus (HBV) Business (2019-2024) & (US$ Million) Table 72. Gilead Sciences Recent Developments Table 73. Novartis Company Details Table 74. Novartis Business Overview Table 75. Novartis Hepatitis B Virus (HBV) Product Table 76. Novartis Revenue in Hepatitis B Virus (HBV) Business (2019-2024) & (US$ Million) Table 77. Novartis Recent Developments Table 78. GlaxoSmithKline Company Details Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Hepatitis B Virus (HBV) Product Table 81. GlaxoSmithKline Revenue in Hepatitis B Virus (HBV) Business (2019-2024) & (US$ Million) Table 82. GlaxoSmithKline Recent Developments Table 83. Hoffmann Company Details Table 84. Hoffmann Business Overview Table 85. Hoffmann Hepatitis B Virus (HBV) Product Table 86. Hoffmann Revenue in Hepatitis B Virus (HBV) Business (2019-2024) & (US$ Million) Table 87. Hoffmann Recent Developments Table 88. La Roche Company Details Table 89. La Roche Business Overview Table 90. La Roche Hepatitis B Virus (HBV) Product Table 91. La Roche Revenue in Hepatitis B Virus (HBV) Business (2019-2024) & (US$ Million) Table 92. La Roche Recent Developments Table 93. Bristol-Myers Squibb Company Details Table 94. Bristol-Myers Squibb Business Overview Table 95. Bristol-Myers Squibb Hepatitis B Virus (HBV) Product Table 96. Bristol-Myers Squibb Revenue in Hepatitis B Virus (HBV) Business (2019-2024) & (US$ Million) Table 97. Bristol-Myers Squibb Recent Developments Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Hepatitis B Virus (HBV) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Hepatitis B Virus (HBV) Market Share by Type: 2023 VS 2030 Figure 3. Therapeutics Features Figure 4. Vaccine Features Figure 5. Global Hepatitis B Virus (HBV) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Hepatitis B Virus (HBV) Market Share by Application: 2023 VS 2030 Figure 7. Hospitals Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Diagnostic Centers Case Studies Figure 10. Hepatitis B Virus (HBV) Report Years Considered Figure 11. Global Hepatitis B Virus (HBV) Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 12. Global Hepatitis B Virus (HBV) Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 13. Global Hepatitis B Virus (HBV) Market Share by Region: 2023 VS 2030 Figure 14. Global Hepatitis B Virus (HBV) Market Share by Players in 2023 Figure 15. Global Top Hepatitis B Virus (HBV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Virus (HBV) as of 2023) Figure 16. The Top 10 and 5 Players Market Share by Hepatitis B Virus (HBV) Revenue in 2023 Figure 17. North America Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 18. North America Hepatitis B Virus (HBV) Market Share by Type (2019-2030) Figure 19. North America Hepatitis B Virus (HBV) Market Share by Application (2019-2030) Figure 20. North America Hepatitis B Virus (HBV) Market Share by Country (2019-2030) Figure 21. United States Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Canada Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Europe Hepatitis B Virus (HBV) Market Size YoY (2019-2030) & (US$ Million) Figure 24. Europe Hepatitis B Virus (HBV) Market Share by Type (2019-2030) Figure 25. Europe Hepatitis B Virus (HBV) Market Share by Application (2019-2030) Figure 26. Europe Hepatitis B Virus (HBV) Market Share by Country (2019-2030) Figure 27. Germany Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. France Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. U.K. Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Italy Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Russia Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Nordic Countries Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. China Hepatitis B Virus (HBV) Market Size YoY (2019-2030) & (US$ Million) Figure 34. China Hepatitis B Virus (HBV) Market Share by Type (2019-2030) Figure 35. China Hepatitis B Virus (HBV) Market Share by Application (2019-2030) Figure 36. Asia Hepatitis B Virus (HBV) Market Size YoY (2019-2030) & (US$ Million) Figure 37. Asia Hepatitis B Virus (HBV) Market Share by Type (2019-2030) Figure 38. Asia Hepatitis B Virus (HBV) Market Share by Application (2019-2030) Figure 39. Asia Hepatitis B Virus (HBV) Market Share by Region (2019-2030) Figure 40. Japan Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. South Korea Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. China Taiwan Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. Southeast Asia Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. India Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Australia Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Size YoY (2019-2030) & (US$ Million) Figure 47. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Share by Type (2019-2030) Figure 48. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Share by Application (2019-2030) Figure 49. Middle East, Africa, and Latin America Hepatitis B Virus (HBV) Market Share by Country (2019-2030) Figure 50. Brazil Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. Mexico Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Turkey Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Saudi Arabia Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Israel Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. GCC Countries Hepatitis B Virus (HBV) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Merck Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2019-2024) Figure 57. Gilead Sciences Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2019-2024) Figure 58. Novartis Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2019-2024) Figure 59. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2019-2024) Figure 60. Hoffmann Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2019-2024) Figure 61. La Roche Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2019-2024) Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2019-2024) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)